Cardiothoracic and Vascular Surgery Working Group, Society of Junior Doctors, Athens, Greece.
Department of Cardiac Surgery, Hygeia Hospital, Athens, Greece.
Asian Cardiovasc Thorac Ann. 2024 Nov;32(8-9):484-493. doi: 10.1177/02184923241301108.
There is little evidence regarding the most beneficial choice between a mechanical and a bioprosthetic valve in the aortic position in dialysis patients. This meta-analysis compares the survival and freedom from reintervention rates between mechanical and bioprosthetic valves in patients on dialysis undergoing aortic valve replacement surgery.
Two databases were searched, and the systematic review was performed in accordance with the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement. We conducted one-stage and two-stage meta-analysis with Kaplan-Meier-derived individual patient data and meta-analysis with random-effects model.
Eight studies were included, providing data about 1215 dialysis patients receiving mechanical valves and 1851 patients receiving bioprosthetic valves. During a mean follow-up of 43.1 months, overall survival rates were significantly improved in the mechanical valve group in comparison to the bioprosthetic one (hazard ratio [HR]: 0.76, 95% confidence interval [CI]: 0.69-0.84, < 0.001). This was confirmed by the two-stage meta-analysis (HR: 0.72, 95% CI: 0.62-0.83, = 0.00, = 17.79%). Regarding freedom from reintervention, no arm offered a statistically significant advantage, according to the two-stage generated analysis (HR: 1.025, 95% CI: 0.65-1.61, = 0.914). Similarly, there was no evident superiority of a valve type for perioperative outcomes.
Mechanical valves are likely to be associated with a better survival outcome compared to bioprosthetic valves for patients on dialysis undergoing aortic valve replacement. However, freedom from reoperation rates and perioperative outcomes were comparable between the two valve types, with no arm exhibiting a statistically significant advantage.
在透析患者中,主动脉瓣位置的机械瓣和生物瓣之间最有益的选择证据有限。本荟萃分析比较了接受主动脉瓣置换术的透析患者中使用机械瓣和生物瓣的生存和免于再次干预率。
检索了两个数据库,并按照系统评价和荟萃分析报告的首选报告项目的建议进行了系统评价。我们使用 Kaplan-Meier 衍生的个体患者数据进行了一阶和二阶荟萃分析,并使用随机效应模型进行了荟萃分析。
纳入了 8 项研究,提供了 1215 例接受机械瓣和 1851 例接受生物瓣的透析患者的数据。在平均 43.1 个月的随访期间,机械瓣组的总生存率明显高于生物瓣组(风险比 [HR]:0.76,95%置信区间 [CI]:0.69-0.84, < 0.001)。这一结果通过二阶荟萃分析得到了证实(HR:0.72,95% CI:0.62-0.83, = 0.00, = 17.79%)。关于免于再次干预,根据二阶生成的分析,两种瓣膜均未提供统计学上显著的优势(HR:1.025,95% CI:0.65-1.61, = 0.914)。同样,两种瓣膜类型在围手术期结局方面也没有明显的优势。
与生物瓣相比,接受主动脉瓣置换术的透析患者使用机械瓣可能具有更好的生存结果。然而,两种瓣膜类型的免于再次手术率和围手术期结局相当,没有任何瓣膜类型具有统计学上显著的优势。